417 related articles for article (PubMed ID: 38370355)
1. Prolactin-secreting pituitary adenomas: male-specific differences in pathogenesis, clinical presentation and treatment.
Dzialach L; Sobolewska J; Zak Z; Respondek W; Witek P
Front Endocrinol (Lausanne); 2024; 15():1338345. PubMed ID: 38370355
[TBL] [Abstract][Full Text] [Related]
2. Prolactin in men's health and disease.
Bolyakov A; Paduch DA
Curr Opin Urol; 2011 Nov; 21(6):527-34. PubMed ID: 21941183
[TBL] [Abstract][Full Text] [Related]
3. The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new.
Chanson P; Maiter D
Best Pract Res Clin Endocrinol Metab; 2019 Apr; 33(2):101290. PubMed ID: 31326373
[TBL] [Abstract][Full Text] [Related]
4. Prolactinomas.
Glezer A; Bronstein MD
Endocrinol Metab Clin North Am; 2015 Mar; 44(1):71-8. PubMed ID: 25732643
[TBL] [Abstract][Full Text] [Related]
5. Hyperprolactinaemia.
Patel SS; Bamigboye V
J Obstet Gynaecol; 2007 Jul; 27(5):455-9. PubMed ID: 17701788
[TBL] [Abstract][Full Text] [Related]
6. Hyperprolactinemia and prolactinoma.
Romijn JA
Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
[TBL] [Abstract][Full Text] [Related]
8. [Hyperprolactinemia unrelated to prolactinoma].
Krysiak R; Okopień B
Wiad Lek; 2014; 67(2 Pt 1):101-11. PubMed ID: 25764785
[TBL] [Abstract][Full Text] [Related]
9. [Current diagnosis and treatment of hyperprolactinemia].
Melgar V; Espinosa E; Sosa E; Rangel MJ; Cuenca D; Ramírez C; Mercado M
Rev Med Inst Mex Seguro Soc; 2016; 54(1):111-21. PubMed ID: 26820213
[TBL] [Abstract][Full Text] [Related]
10. [Prolactinoma].
Glezer A; Bronstein MD
Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):118-23. PubMed ID: 24830588
[TBL] [Abstract][Full Text] [Related]
11. Controversial issues in the management of hyperprolactinemia and prolactinomas - An overview by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism.
Vilar L; Abucham J; Albuquerque JL; Araujo LA; Azevedo MF; Boguszewski CL; Casulari LA; Cunha Neto MBC; Czepielewski MA; Duarte FHG; Faria MDS; Gadelha MR; Garmes HM; Glezer A; Gurgel MH; Jallad RS; Martins M; Miranda PAC; Montenegro RM; Musolino NRC; Naves LA; Ribeiro-Oliveira Júnior A; Silva CMS; Viecceli C; Bronstein MD
Arch Endocrinol Metab; 2018; 62(2):236-263. PubMed ID: 29768629
[TBL] [Abstract][Full Text] [Related]
12. GIANT PROLACTINOMA. A CASE REPORT.
Šulavíková Z; Krásnik V
Cesk Slov Oftalmol; 2023; 79(3):143-148. PubMed ID: 37344216
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of pituitary adenomas].
Mezosi E; Nemes O
Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement.
Petersenn S; Fleseriu M; Casanueva FF; Giustina A; Biermasz N; Biller BMK; Bronstein M; Chanson P; Fukuoka H; Gadelha M; Greenman Y; Gurnell M; Ho KKY; Honegger J; Ioachimescu AG; Kaiser UB; Karavitaki N; Katznelson L; Lodish M; Maiter D; Marcus HJ; McCormack A; Molitch M; Muir CA; Neggers S; Pereira AM; Pivonello R; Post K; Raverot G; Salvatori R; Samson SL; Shimon I; Spencer-Segal J; Vila G; Wass J; Melmed S
Nat Rev Endocrinol; 2023 Dec; 19(12):722-740. PubMed ID: 37670148
[TBL] [Abstract][Full Text] [Related]
15. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas.
Casanueva FF; Molitch ME; Schlechte JA; Abs R; Bonert V; Bronstein MD; Brue T; Cappabianca P; Colao A; Fahlbusch R; Fideleff H; Hadani M; Kelly P; Kleinberg D; Laws E; Marek J; Scanlon M; Sobrinho LG; Wass JA; Giustina A
Clin Endocrinol (Oxf); 2006 Aug; 65(2):265-73. PubMed ID: 16886971
[TBL] [Abstract][Full Text] [Related]
16. Update on prolactinomas. Part 2: Treatment and management strategies.
Wong A; Eloy JA; Couldwell WT; Liu JK
J Clin Neurosci; 2015 Oct; 22(10):1568-74. PubMed ID: 26243714
[TBL] [Abstract][Full Text] [Related]
17. Hyperprolactinemia: pathophysiology and management.
Verhelst J; Abs R
Treat Endocrinol; 2003; 2(1):23-32. PubMed ID: 15871552
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and Treatment of Pituitary Adenomas: A Review.
Molitch ME
JAMA; 2017 Feb; 317(5):516-524. PubMed ID: 28170483
[TBL] [Abstract][Full Text] [Related]
19. Serum Prolactin Level to Tumor Size Ratio as a Potential Parameter for Preoperative Differentiation of Prolactinomas from Hyperprolactinemia-Causing Non-functional Pituitary Adenomas.
Kim JH; Hur KY; Hong SD; Choi JW; Seol HJ; Nam DH; Lee JI; Kong DS
World Neurosurg; 2022 Mar; 159():e488-e496. PubMed ID: 34958988
[TBL] [Abstract][Full Text] [Related]
20. [Overcoming therapy resistance in prolactinomas: from perspectives to real clinical practice].
Shutova AS; Pigarova EA; Lepeshkina LI; Ioutsi VA; Drokov MY; Vorotnikova SY; Astafyeva LI; Dzeranova LK
Probl Endokrinol (Mosk); 2024 Jan; 69(6):63-69. PubMed ID: 38311996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
